{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:05:55Z","timestamp":1771272355225,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004776","name":"Chulalongkorn University Faculty of Medicine","doi-asserted-by":"publisher","award":["RA62\/122"],"award-info":[{"award-number":["RA62\/122"]}],"id":[{"id":"10.13039\/501100004776","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.vhri.2024.101030","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T15:36:56Z","timestamp":1722440216000},"page":"101030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Health Utility Values Among Patients With Diabetic Retinopathy, Wet Age-Related Macular Degeneration, and Cataract in Thailand: A Multicenter Survey Using Time Trade-Off, EQ-5D-5L, and Health Utility Index 3"],"prefix":"10.1016","volume":"44","author":[{"given":"Pear Ferreira","family":"Pongsachareonnont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phantipa","family":"Sakthong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Voraporn","family":"Chaikitmongkol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wantanee Dangboon","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chavakij","family":"Bhoomibunchoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron P.","family":"Hurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yot","family":"Teerawattananon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kittisak","family":"Kulvichit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vhri.2024.101030_bib2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4093\/dmj.2018.0182","article-title":"Pathophysiology of diabetic retinopathy: the old and the new. Blindness and vision impairment","volume":"42","author":"Kusuhara","year":"2013","journal-title":"Diabetes Metab J"},{"issue":"14","key":"10.1016\/j.vhri.2024.101030_bib3","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93751","article-title":"Diabetic retinopathy: current understanding, mechanisms, and treatment strategies","volume":"2","author":"Duh","year":"2017","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.vhri.2024.101030_bib4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/ceo.12696","article-title":"Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review","volume":"44","author":"Ting","year":"2016","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.vhri.2024.101030_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00004397-200404440-00004","article-title":"The epidemiology of age-related macular degeneration","volume":"44","author":"Seddon","year":"2004","journal-title":"Int Ophthalmol Clin"},{"issue":"1","key":"10.1016\/j.vhri.2024.101030_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.gendis.2021.02.009","article-title":"Age-related macular degeneration: epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy","volume":"9","author":"Deng","year":"2022","journal-title":"Genes Dis"},{"issue":"1","key":"10.1016\/j.vhri.2024.101030_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0002-9394(03)00226-5","article-title":"Cataract treatment in the beginning of the 21st century","volume":"136","author":"Olson","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.vhri.2024.101030_bib8","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/heapol\/czl018","article-title":"Calculating QALYs, comparing QALY and DALY calculations","volume":"21","author":"Sassi","year":"2006","journal-title":"Health Policy Plan"},{"issue":"6","key":"10.1016\/j.vhri.2024.101030_bib9","first-page":"1832","article-title":"Population-level cost-effectiveness of implementing evidence-based practices into routine care","volume":"49","author":"Fortney","year":"2014","journal-title":"Health Serv Res"},{"issue":"2","key":"10.1016\/j.vhri.2024.101030_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0168-8510(02)00059-3","article-title":"The development of health technology assessment","volume":"63","author":"Banta","year":"2003","journal-title":"Health Policy"},{"issue":"5","key":"10.1016\/j.vhri.2024.101030_bib11","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ophtha.2007.06.008","article-title":"The impact of anchor point on utilities for 5 common ophthalmic diseases","volume":"115","author":"Lee","year":"2008","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.vhri.2024.101030_bib12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0002-9394(99)00146-4","article-title":"Utility values and diabetic retinopathy","volume":"128","author":"Brown","year":"1999","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.vhri.2024.101030_bib13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/eye.2011.218","article-title":"Validity of EuroQOL-5D, time trade-off, and standard gamble for age-related macular degeneration in the Singapore population","volume":"26","author":"Au Eong","year":"2012","journal-title":"Eye (Lond)"},{"issue":"4","key":"10.1016\/j.vhri.2024.101030_bib14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10198-019-01156-w","article-title":"A\u00a0vision \u201cbolt-on\u201d increases the responsiveness of EQ-5D: preliminary evidence from a study of cataract surgery","volume":"21","author":"Gandhi","year":"2020","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.vhri.2024.101030_bib15","author":"Sutjaritban"},{"issue":"4","key":"10.1016\/j.vhri.2024.101030_bib16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0161-6420(00)00635-7","article-title":"Quality of life associated with unilateral and bilateral good vision","volume":"108","author":"Brown","year":"2001","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.vhri.2024.101030_bib17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/0272989X14543107","article-title":"Comparing and explaining differences in the magnitude, content, and sensitivity of utilities predicted by the EQ-5D, SF-6D, HUI 3, 15D, QWB, and AQoL-8D multiattribute utility instruments","volume":"35","author":"Richardson","year":"2015","journal-title":"Med Decis Making"},{"issue":"6","key":"10.1016\/j.vhri.2024.101030_bib18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0021-9681(87)90019-1","article-title":"Utility approach to measuring health-related quality of life","volume":"40","author":"Torrance","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"issue":"5","key":"10.1016\/j.vhri.2024.101030_bib20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/14737167.2018.1494574","article-title":"The EQ-5D-5L valuation study in Thailand","volume":"18","author":"Pattanaphesaj","year":"2018","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"8","key":"10.1016\/j.vhri.2024.101030_bib21","doi-asserted-by":"crossref","first-page":"e783","DOI":"10.1111\/aos.13430","article-title":"Visual and health outcomes, measured with the activity inventory and the EQ-5D, in visual impairment","volume":"95","author":"Macedo","year":"2017","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.vhri.2024.101030_bib22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12955-022-02043-4","article-title":"Predictors of problems reported on the EQ-5D-3L dimensions among people with impaired vision in northern Portugal","volume":"20","author":"Macedo","year":"2022","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"10.1016\/j.vhri.2024.101030_bib23","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1464-5491.2008.02430.x","article-title":"Health utility values associated with diabetic retinopathy","volume":"25","author":"Lloyd","year":"2008","journal-title":"Diabet Med"},{"issue":"11","key":"10.1016\/j.vhri.2024.101030_bib24","first-page":"1307","article-title":"A\u00a0systematic literature review of utility weights in wet age-related macular degeneration","volume":"16","author":"Pearson","year":"2013","journal-title":"J\u00a0Med Econ"},{"issue":"1","key":"10.1016\/j.vhri.2024.101030_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jval.2011.08.002","article-title":"A\u00a0review of generic preference-based measures of health-related quality of life in visual disorders","volume":"15","author":"Tosh","year":"2012","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.vhri.2024.101030_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1076\/opep.9.2.83.1523","article-title":"A\u00a0simplified cataract grading system. The WHO Cataract Grading Group","volume":"9","author":"Thylefors","year":"2022","journal-title":"Ophthal Epidemiol"},{"issue":"3","key":"10.1016\/j.vhri.2024.101030_bib27","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1167\/iovs.05-0981","article-title":"Visual acuities \u201chand motion\u201d and \u201ccounting fingers\u201d can be quantified with the Freiburg visual acuity test","volume":"47","author":"Schulze-Bonsel","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.vhri.2024.101030_bib29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.vhri.2024.101030_bib30","series-title":"The Measurement and Valuation of Health: A Chronicle","author":"Williams","year":"1995"},{"issue":"1 suppl 1","key":"10.1016\/j.vhri.2024.101030_bib31","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1007\/s10198-013-0503-2","article-title":"Introducing the composite time trade-off: a test of feasibility and face validity","volume":"14","author":"Janssen","year":"2013","journal-title":"Eur J Health Econ"},{"issue":"5","key":"10.1016\/j.vhri.2024.101030_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.35755\/jmedassocthai.2022.05.13307","article-title":"Effect of feasibility and religion on health utility questionnaire responses of elderly ophthalmic patients: a pilot study","volume":"105","author":"Pongsachareonnont","year":"2022","journal-title":"J\u00a0Med Assoc Thai"},{"key":"10.1016\/j.vhri.2024.101030_bib33","series-title":"Health-Related Quality of Life Measure (EQ-5D-5L): Measurement Property Testing and Its Preference-Based Score in Thai Population","author":"Pattanaphesaj","year":"2014"},{"issue":"7","key":"10.1016\/j.vhri.2024.101030_bib34","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s11136-012-0297-1","article-title":"The psychometric testing of the Thai version of the health utilities index in patients with ischemic heart disease","volume":"22","author":"Saiguay","year":"2013","journal-title":"Qual Life Res"},{"issue":"2","key":"10.1016\/j.vhri.2024.101030_bib35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005650-200202000-00006","article-title":"Multiattribute and single-attribute utility functions for the health utilities index Mark 3 system","volume":"40","author":"Feeny","year":"2002","journal-title":"Med Care"},{"issue":"7","key":"10.1016\/j.vhri.2024.101030_bib36","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","article-title":"Development of the 25-item National Eye Institute visual function questionnaire","volume":"119","author":"Mangione","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.vhri.2024.101030_bib37","first-page":"249","article-title":"Validation of a disease-specific questionnaire for health-related quality of life in Thai. Songklanagarind","volume":"27","author":"Setthawatcharawanich","year":"2009","journal-title":"Med J"},{"issue":"9","key":"10.1016\/j.vhri.2024.101030_bib38","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/archopht.121.9.1297","article-title":"Vision-related quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute visual function questionnaire","volume":"121","author":"Deramo","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.vhri.2024.101030_bib39","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1167\/iovs.09-4494","article-title":"The psychometric validity of the NEI VFQ-25 for use in a low-vision population","volume":"51","author":"Marella","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.vhri.2024.101030_bib40","first-page":"43","article-title":"Organizational research: determining appropriate sample size in survey research","volume":"19","author":"Bartlett","year":"2001","journal-title":"Inf Technol Learn Perform J"},{"key":"10.1016\/j.vhri.2024.101030_bib41","series-title":"Encyclopedia of Statistics in Behavioral Science","first-page":"1570","article-title":"Power and sample size in multilevel linear models","author":"Snijders","year":"2005"},{"issue":"8","key":"10.1016\/j.vhri.2024.101030_bib42","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jval.2020.12.019","article-title":"Health state utility values for type 2 diabetes and related complications in east and Southeast Asia: a systematic review and meta-analysis","volume":"24","author":"Mok","year":"2021","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.vhri.2024.101030_bib43","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archopht.120.4.481","article-title":"Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration","volume":"120","author":"Brown","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.vhri.2024.101030_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1076\/opep.11.1.43.26436","article-title":"TTO utility scores measure quality of life in patients with visual morbidity due to diabetic retinopathy or ARMD","volume":"11","author":"Shah","year":"2004","journal-title":"Ophthal Epidemiol"},{"issue":"8","key":"10.1016\/j.vhri.2024.101030_bib45","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jamaoto.2015.1314","article-title":"Comparison of health state utility measures in patients with head and neck cancer","volume":"141","author":"Noel","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"8","key":"10.1016\/j.vhri.2024.101030_bib46","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10198-014-0636-y","article-title":"Differences in eq-5d-3l health state valuations among patients with musculoskeletal diseases, health care professionals and healthy volunteers","volume":"16","author":"Schwalm","year":"2015","journal-title":"Eur J Health Econ"},{"issue":"3","key":"10.1016\/j.vhri.2024.101030_bib47","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jval.2011.11.031","article-title":"QALY weights for diabetic retinopathy\u2014a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO","volume":"15","author":"Heintz","year":"2012","journal-title":"Value Health"},{"issue":"11","key":"10.1016\/j.vhri.2024.101030_bib48","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1167\/iovs.05-0072","article-title":"The impact of age-related macular degeneration on health status utility values","volume":"46","author":"Espallargues","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.vhri.2024.101030_bib49","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jval.2015.08.002","article-title":"A\u00a0vision \u201cbolt-on\u201d item could increase the discriminatory power of the EQ-5D index score","volume":"18","author":"Luo","year":"2015","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.vhri.2024.101030_bib50","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/09286586.2014.888456","article-title":"Mapping the 25-item National Eye Institute visual functioning questionnaire (NEI VFQ-25) to EQ-5D utility scores","volume":"21","author":"Kay","year":"2014","journal-title":"Ophthal Epidemiol"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109924000633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109924000633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:35:05Z","timestamp":1762605305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109924000633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":47,"alternative-id":["S2212109924000633"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2024.101030","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health Utility Values Among Patients With Diabetic Retinopathy, Wet Age-Related Macular Degeneration, and Cataract in Thailand: A Multicenter Survey Using Time Trade-Off, EQ-5D-5L, and Health Utility Index 3","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2024.101030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101030"}}